Theranostic Potential of [177Lu]Lu-DOTA-Tocilizumab in Multiple Myeloma: A Preclinical Evaluation.

Saved in:
Bibliographic Details
Title: Theranostic Potential of [177Lu]Lu-DOTA-Tocilizumab in Multiple Myeloma: A Preclinical Evaluation.
Authors: Camacho X; Department of Radiopharmacy, Nuclear Research Centre, Faculty of Sciences, University of the Republic, Montevideo, Uruguay., Cabrera M; Department of Radiopharmacy, Nuclear Research Centre, Faculty of Sciences, University of the Republic, Montevideo, Uruguay., Perroni C; Department of Radiopharmacy, Nuclear Research Centre, Faculty of Sciences, University of the Republic, Montevideo, Uruguay., Tassano M; Department of Radiopharmacy, Nuclear Research Centre, Faculty of Sciences, University of the Republic, Montevideo, Uruguay., Fernández M; Department of Radiopharmacy, Nuclear Research Centre, Faculty of Sciences, University of the Republic, Montevideo, Uruguay., Oddone N; Department of Trypanosome Redox Biology, Pasteur Institute of Montevideo, Montevideo, Uruguay., Riva E; Chair of Haematology, Hospital of Clinics, Faculty of Medicine, University of the Republic, Montevideo, Uruguay., Gambini JP; Centre for Nuclear Medicine and Molecular Imaging, Hospital of Clinics, Faculty of Medicine, University of the Republic, Montevideo, Uruguay., Cabral P; Department of Radiopharmacy, Nuclear Research Centre, Faculty of Sciences, University of the Republic, Montevideo, Uruguay.
Source: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2026 Mar 10. Date of Electronic Publication: 2026 Mar 10.
Publication Type: Journal Article
Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101265649 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-5992 (Electronic) Linking ISSN: 18715206 NLM ISO Abbreviation: Anticancer Agents Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-5992
DOI:10.2174/0118715206406408251125050709